Lymphocytes in Autoimmunity T-bet Regulates the Fate of Th1 and Th17

Lovett-RackeHussain, Sara C. Northrop, Michael K. Racke and Amy E. Anne R. Gocke, Petra D. Cravens, Li-Hong Ben, Rehana Z.http://www.jimmunol.org/content/178/3/1341J Immunol€2007; 178:1341-1348; ;Referenceshttp://www.jimmunol.org/content/178/3/1341.full#ref-list-1This article cites 35 articles, 15 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[2]  M. Kurrer,et al.  T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17 , 2006, The Journal of experimental medicine.

[3]  M. Racke,et al.  Peroxisome proliferator-activated receptor-α and retinoid X receptor agonists inhibit inflammatory responses of astrocytes , 2006, Journal of Neuroimmunology.

[4]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[5]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[6]  L. Presta,et al.  Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. , 2006, The Journal of clinical investigation.

[7]  T. Huang,et al.  T-bet Binding to Newly Identified Target Gene Promoters Is Cell Type-independent but Results in Variable Context-dependent Functional Effects*♦ , 2006, Journal of Biological Chemistry.

[8]  B. Birnir,et al.  Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE , 2006, Nature Medicine.

[9]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[10]  L. Glimcher,et al.  Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. , 2006, The Journal of clinical investigation.

[11]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[12]  M. Goldman,et al.  IL‐23 up‐regulates IL‐10 and induces IL‐17 synthesis by polyclonally activated naive T cells in human , 2005, European journal of immunology.

[13]  L. Glimcher,et al.  T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[15]  V. Kuchroo,et al.  IL-12– and IL-23–induced T helper cell subsets , 2005, The Journal of experimental medicine.

[16]  A. Lovett-racke,et al.  Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. , 2004, Immunity.

[17]  Toshifumi Hibi,et al.  T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn’s disease , 2004, Gut.

[18]  S. Szabo,et al.  Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.

[19]  L. Glimcher,et al.  T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes , 2004, The Journal of experimental medicine.

[20]  M. Kamoun,et al.  Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia , 2003, Journal of the Neurological Sciences.

[21]  B. Becher,et al.  IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. , 2003, The Journal of clinical investigation.

[22]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[23]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[24]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[25]  S. Szabo,et al.  Distinct Effects of T-bet in TH1 Lineage Commitment and IFN-γ Production in CD4 and CD8 T Cells , 2002, Science.

[26]  S. Szabo,et al.  Development of Spontaneous Airway Changes Consistent with Human Asthma in Mice Lacking T-bet , 2002, Science.

[27]  M. Neurath,et al.  Treatment of Allergic Airway Inflammation and Hyperresponsiveness by Antisense-Induced Local Blockade of Gata-3 Expression , 2001, The Journal of experimental medicine.

[28]  Xiao-Jun Ma,et al.  Tbt-1, a new T-box transcription factor induced in activated Th1 and CD8+ T cells , 2000, Immunogenetics.

[29]  Laurie H Glimcher,et al.  A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.

[30]  P. Kivisäkk,et al.  Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis , 1999, Multiple sclerosis.

[31]  L. Hood,et al.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.

[32]  Jianfei Yang,et al.  T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells , 2002, Nature Immunology.